Modern Healthcare (10/19, Bannow, Subscription Publication) reports “all of the health systems that responded to a recent” Kaufman Hall survey “expect it will be at least 2022 before their operations return to anything resembling a pre-pandemic ‘normal.’” The survey, conducted in August, “included 64 mostly hospital and health system respondents,” of which, “nearly three-quarters of respondents said they were moderately or extremely concerned about the financial viability of their organizations in the absence of an effective COVID-19 vaccine or treatment.” One-third “said they experienced year-over-year operating margin declines in excess of 100% between the second quarter of 2019 and the second quarter of 2020.”

Related Links:

— “Pre-pandemic ‘normal’ not expected until 2022, hospital execs say “Tara Bannow, Modern healthcare, October 19, 2020

MedPage Today (10/19, George) reports the narcolepsy medications “modafinil (Provigil) and armodafinil (Nuvigil) were both associated with major congenital malformations,” investigators concluded in “a post-marketing report.” That report revealed that “of 102 prospective live births in the U.S. Provigil/Nuvigil Pregnancy Registry, 13% had major congenital malformations, considerably above the prevalence of about 3% in the general population.” The findings were published online in a research letter in JAMA Internal Medicine.

Related Links:

— MedPage Today (requires login and subscription)

Medscape (10/19, Greb, Subscription Publication) reports researchers found “insomnia with objective short sleep duration is associated with a significantly increased risk of cognitive impairment, particularly as it relates to cardiometabolic health.” The findings were published in Sleep.

Related Links:

— Medscape (requires login and subscription)

Healio (10/19, Gramigna) reports, “Individuals with visual and/or hearing impairments were at increased risk for cognitive decline and depression,” investigators concluded after “analyzing data of 18,038 participants of a 2015 survey of the China Health and Retirement Longitudinal Study, which collected responses of adults aged 45 years or older and their spouses.” The findings of the “cross-sectional study” were published online in JAMA Network Open.

Related Links:

— “Visual, hearing impairments may increase risk for cognitive decline, depression “Joe Gramigna, Healio, October 19, 2020

HealthDay (10/16, Preidt) reported, “Women who suffer severe morning sickness may have higher risk of depression during and after pregnancy,” investigators concluded in a study that “enrolled 214 women in London during the first trimester of pregnancy.” Half of the participants “had severe morning sickness; half did not.” The findings were published online Oct. 14 in BMJ Open.

Related Links:

— “Severe Morning Sickness Linked to Depression Before and After Birth “Robert Preidt, HealthDay, October 16, 2020